Atopy can manifest in childhood as infantile eczema (atopic dermatitis), allergic rhinitis and asthma. In practice, it is critical to
identify the offending allergen in atopic individuals. This will not only influence therapeutic interventions, but may also have a
significant impact on the individual’s quality of life. The most common clinical test for allergy detection is the introduction of
an allergen directly into the skin in the form of a skin-prick test. Skin-prick testing is recommended in the diagnostic workup
for allergies because it is reliable, safe, convenient, inexpensive, minimally invasive, and has the advantage of multiple
allergen testing in one, 15- to 20-minute, test. Skin-prick testing can be performed from birth onwards. Although there is
a small risk of developing anaphylaxis, the test remains safe to perform in a consultation room or at the patient’s bedside.
Worldwide, a skin-prick test remains the test of choice for allergy because of its convenience and cost-effectiveness.
A globally accepted guideline for skin-prick testing is still lacking and would be beneficial to both patient and physician.